In this context, in silico data analysis of a cohort of PCa patient samples [47] revealed that GPX4 expression is more elevated in castration‐resistant prostate cancer (CRPC) tissues compared to normal prostate (Fig. 1A). Here, GPX4 is linked to posterior cortical atrophy.